Saturday, April 11, 2015

Top High Tech Stocks To Own Right Now

Top High Tech Stocks To Own Right Now: Omeros Corporation(OMER)

Omeros Corporation, a clinical-stage biopharmaceutical company, engages in discovering, developing, and commercializing products targeting inflammation, coagulopathies, and disorders of the central nervous system. Its product candidates are derived from its proprietary PharmacoSurgery platform that is designed to improve clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological, and other surgical and medical procedures. The company?s lead PharmacoSurgery product candidates include OMS103HP, a Phase 3 clinical program evaluated for OMS103HP?s safety and ability to improve postoperative joint function and reduce pain following arthroscopic partial meniscectomy surgery, and arthroscopic anterior cruciate ligament; OMS302, a Phase 2b clinical trial completed product candidate for use during ophthalmological procedures, including cataract and other lens replacement surgery; and OMS201, a Phase 1/Phase 2 clinical trial completed program for use durin g urological surgery. It also engages in developing proprietary compositions that comprise peroxisome proliferator-activated receptor gamma agonists for the treatment and prevention of addiction to substances of abuse. The company?s pipeline of preclinical product development programs includes Plasmin for Surgical and traumatic bleeding; PDE7 for addictions and compulsive disorders, and movement disorders; MASP-2 for macular degeneration, ischemia-reperfusion injury, transplant surgery, and radiation injury; and PDE10 for Schizophrenia. Omeros Corporation was founded in 1994 and is based in Seattle, Washington.

Advisors' Opinion:
  • [By John Udovich]

    Last week had been a busy week for biotech IPOs and follow-on offerings plus news from small cap biotech stocks like Omeros Corporation (NASDAQ: OMER), Argos Therapeutics Inc (NASDAQ: ARGS), Revanc! e Therapeutics Inc (NASDAQ: RVNC) and TNI BioTech (OTCMKTS: TNIB) that's worth noting as a new trading week begins: 

  • [By John Udovich]

    The biotech sector has been hot this year with small cap biotech stocks Fate Therapeutics Inc (NASDAQ: FATE), Omeros Corporation(NASDAQ: OMER) and TNI BioTech (OTCMKTS: TNIB) being among those biotech stocks in the news this week. However, there has also been talk and perhaps some signs of a bubble in biotech that investors and traders alike need to consider. With that in mind, here is a recap of the latest news for biotech or small cap biotech stocks:

  • [By John Udovich]

    Small cap orphan drug stocks Zalicus Inc (NASDAQ: ZLCS), Omeros Corporation (NASDAQ: OMER) and Viropharma Inc (NASDAQ: VPHM) have been active lately thanks to good news about their orphan drug treatments. In case you aren't familiar with the term, orphan drug designation by the FDA is granted for drugs targeting conditions affecting 200,000 or fewer US patients annually that are expected to provide significant therapeutic advantage over existing treatments. The designation will also qualify companies for benefits across all stages of drug development, such as accelerated approval processes, seven years of market exclusivity after marketing approval, tax credits on any US clinical trials, grants and waiver of certain administrative fees.

  • source from Top Stocks For 2015:

No comments:

Post a Comment